“Complement C1QC As a Potential Prognostic Marker and Therapeutic Target in Colon Carcinoma Based on Single-Cell RNA Sequencing and Immunohistochemical Analysis”. 2022. Biomolecules and Biomedicine 22 (6): 912-22. https://doi.org/10.17305/bjbms.2022.7309.